| 000 | 01818 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515061251.0 | ||
| 264 | 0 | _c20070425 | |
| 008 | 200704s 0 0 eng d | ||
| 022 | _a0959-4973 | ||
| 024 | 7 |
_a10.1097/CAD.0b013e328012bccd _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aXie, Ming | |
| 245 | 0 | 0 |
_aIntratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cApr 2007 |
||
| 300 |
_a459-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aCapillaries _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xmetabolism |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aLactic Acid |
| 650 | 0 | 4 |
_aLaryngeal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicrospheres |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPolyglycolic Acid |
| 650 | 0 | 4 | _aPolylactic Acid-Polyglycolic Acid Copolymer |
| 650 | 0 | 4 | _aPolymers |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 700 | 1 | _aZhou, Liang | |
| 700 | 1 | _aHu, Tao | |
| 700 | 1 | _aYao, Ming | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 18 _gno. 4 _gp. 459-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0b013e328012bccd _zAvailable from publisher's website |
| 999 |
_c16907611 _d16907611 |
||